IP Library Granted Patent US 7,070,955
Granted Patent B2
US 7,070,955 · App. 09/989,733 · Granted Jul 4, 2006

Secreted and transmembrane polypeptides and nucleic acids encoding the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,070,955
App. No.
09/989,733
Granted
Jul 4, 2006
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (11)

1. An isolated nucleic acid comprising:

(a) the nucleic acid sequence of SEQ ID NO:398;

(b) the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:398; or

(c) the full-length coding sequence of the cDNA deposited under ATCC accession number 203095.

2. The isolated nucleic acid of claim 1 comprising the nucleic acid sequence of SEQ ID NO:398.

3. The isolated nucleic acid of claim 1 comprising the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:398.

4. The isolated nucleic acid of claim 1 comprising the full-length coding sequence of the cDNA deposited under ATCC accession number 203095.

5. A vector comprising the nucleic acid of claim 1 .

6. The vector of claim 5 , wherein said nucleic acid is operably linked to control sequences recognized by a host cell transformed with the vector.

7. A host cell comprising the vector of claim 5 .

8. The host cell of claim 7 , wherein said cell is a CHO cell, an E. coli or a yeast cell.